Tanomastat is a synthetic matrix metalloproteinase inhibitor, an agent historically investigated for its potential to modulate tissue remodeling and treat conditions involving extracellular matrix degradation.… Read more
Tanomastat is a synthetic matrix metalloproteinase inhibitor, an agent historically investigated for its potential to modulate tissue remodeling and treat conditions involving extracellular matrix degradation. This category offers high-quality reference standards for Tanomastat, including its specific (R)-enantiomer, to support rigorous pharmaceutical research and development. Laboratories rely on these analytical standards for method validation, quantitative analysis, and precise impurity profiling throughout the drug development lifecycle. By utilizing these chemically accurate reference materials, researchers can ensure the integrity of their analytical processes, whether conducting stability testing, developing new separation methods, or performing comparative studies on metabolite pathways. These compounds are essential tools for maintaining quality control standards during the characterization and regulatory assessment of this compound and related therapeutic candidates in the laboratory environment.